CC vs CE vs LYB Stock Comparison

Chemours, Celanese and LyondellBasell Industries Prices as of Nov 13, 2026 Peers: Industry group
1 more company in this comparison (BAK) Create a free account to keep reading and compare up to 10 companies.
CC Chemours Co
$13.28 +3.3% 1M +8.2% 1Y
Market cap
$1.89B
P/E
–
Revenue (TTM)
$5.84B
Div. yield
0.03%
Commodity Chemicals Basic Materials
1 win
CE Celanese Corp
$51.41 +12.2% 1M +28.6% 1Y
Market cap
$5.39B
P/E
20.6x
Revenue (TTM)
$9.85B
Div. yield
0.00%
Commodity Chemicals Basic Materials
1 win

Head to Head

12 decided of 12

LyondellBasell Industries leads on 10 of the 12 questions below (LyondellBasell Industries 10, Celanese 1, Chemours 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCCCELYBLeader
Larger companyMarket capitalisation $1.89B $5.39B $39.96B LYB
Cheaper on earningsLower P/E, profitable companies only -12.3x 20.6x 30.9x CE
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.1x 8.0x 7.0x LYB
Faster revenue growthRevenue growth, trailing twelve months +0.1% +1.6% +3.5% LYB
More profitableNet margin, trailing twelve months -2.6% 2.7% 4.1% LYB
Better return on capitalReturn on invested capital 0.0% 4.1% 9.0% LYB
Less leveragedLower net debt / EBITDA 8.6x 6.2x 2.2x LYB
Higher dividend yieldTrailing dividend yield 0.03% 0.00% 0.03% CC
Better 1-year returnPrice return, last 12 months +8.2% +28.6% +41.5% LYB
Better 5-year returnAnnualised price return, 5 years -16.7%/yr -21.3%/yr -7.6%/yr LYB
Less volatileAnnualised volatility, 1 year 61.9% 49.6% 42.7% LYB
Higher overall scoreMean of the five percentile scores vs peers 49/100 42/100 59/100 LYB

Percentile Scorecard

CCCELYB

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCCCELYB
Valuation 57 #42 of 96 80 #20 of 96 66 #33 of 96
Growth 88 #12 of 92 25 #69 of 92 70 #28 of 92
Profitability 41 #53 of 89 59 #37 of 89 72 #26 of 89
Financial Health 18 #79 of 96 16 #81 of 96 44 #54 of 96
Shareholder Returns 40 #48 of 79 31 #55 of 79 45 #44 of 79
Overall 49 42 59
  • CC ranked among 99 companies in Chemicals
  • CE ranked among 99 companies in Chemicals
  • LYB ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCCCELYBSPY
1 month +3.3%+12.2%+5.3% -2.0%
3 months -16.2%+12.6%+1.0% -2.8%
6 months -42.6%-9.5%-14.2% +2.0%
Year to date +12.6%+21.6%+48.8% +10.6%
1 year +8.2%+28.6%+41.5% +12.2%
3 years -50.5%-59.1%-33.2% +68.1%
3 years, per year -20.9%-25.8%-12.6% +18.9%
5 years -60.0%-69.8%-32.5% +61.4%
5 years, per year -16.7%-21.3%-7.6% +10.1%
10 years -35.9%-33.2%-21.6% +248.5%
10 years, per year -4.3%-4.0%-2.4% +13.3%

Risk

MeasureCCCELYBSPY
Volatility, 1Y 61.9%49.6%42.7% 13.6%
Downside volatility, 1Y 68.2%45.5%40.8% 13.9%
Beta vs S&P 500, 1Y 1.450.50-0.57 1.00
Return / volatility, 1Y 0.130.580.97 0.90
Max drawdown, 5Y -79.0%-79.6%-63.9% -25.4%
From 52-week high -52.5%-25.8%-21.8% -3.2%
52-week high $27.94$69.24$82.38 $779.14
52-week low $10.48$35.53$42.28 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCCCELYB
P/E now vs peer median -13.0xmedian 23.4x 21.5xmedian 23.4x 32.1xmedian 23.4x
P/S now vs peer median 0.3xmedian 1.3x 0.6xmedian 1.3x 1.3xmedian 1.3x
EV/EBITDA now vs peer median 14.0xmedian 12.7x 9.6xmedian 12.7x 12.0xmedian 12.7x
P/FCF now vs peer median 9.5xmedian 17.0x 7.1xmedian 17.0x 17.2xmedian 17.0x
P/B now vs peer median 12.8xmedian 1.5x 1.2xmedian 1.5x 3.7xmedian 1.5x
PEG now vs peer median -0.60median 1.72 -0.43median 1.72 -1.89median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCCCELYB
Revenue $5.84B $9.85B $31.96B
Gross profit $885.00M $2.05B $4.57B
Operating income $37.00M $781.00M $2.76B
Net income -$154.00M $274.00M $1.30B
Free cash flow $211.00M $794.00M $2.41B
R&D $104.00M $118.00M $138.00M
EPS (diluted) $-1.01 $2.38 $2.00
Cash & equivalents $698.00M $1.36B $3.23B
Total debt $3.83B $11.55B $12.33B
Shares (diluted) 151.91M 110.20M 646.00M
Enterprise value -$711.88M -$359.22M $28.03B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCCCELYB
P/E -13.0x 21.5x 32.1x
P/FCF 9.5x 7.1x 17.2x
P/Operating cash flow 5.0x 5.2x 11.2x
P/S 0.3x 0.6x 1.3x
P/B 12.8x 1.2x 3.7x
P/Tangible book 13.0x 3.5x 3.8x
EV/EBITDA 14.0x 9.6x 12.0x
EV/EBIT 138.8x 20.3x 18.4x
EV/Revenue 0.9x 1.6x 1.6x
EV/FCF 24.3x 19.9x 21.0x
EV/Operating cash flow 12.8x 14.7x 13.7x
PEG (3Y EPS CAGR) -0.60 -0.43 -1.89

Growth

14 metrics
MetricCCCELYB
Revenue growth (1Y) 0.1% 1.6% 3.5%
Revenue CAGR (3Y) -1.2% -2.8% -8.2%
Gross profit growth (1Y) -12.5% -0.3% 50.0%
Gross profit CAGR (3Y) -10.9% -4.8% -3.7%
Operating income growth (1Y) 1,133% 134.0% 397.2%
Operating income CAGR (3Y) 29.0% -19.3% -5.0%
Net income growth (1Y) 55.9% 108.8% 208.4%
Net income CAGR (3Y) 21.3% -48.7% -17.1%
EPS growth (1Y) 56.3% 108.4% 206.9%
EPS CAGR (3Y) 21.6% -49.6% -17.0%
Operating cash flow growth (1Y) 50.9% -22.6% 38.8%
Operating cash flow CAGR (3Y) 19.4% -12.6% -9.8%
Free cash flow growth (1Y) 1,858% -22.5% 227.1%
Free cash flow CAGR (3Y) 72.7% -8.2% -11.8%

Profitability

14 metrics
MetricCCCELYB
Gross margin 15.2% 20.8% 14.3%
EBITDA margin 6.3% 16.8% 13.2%
Operating margin 0.6% 7.9% 8.6%
Pretax margin 2.3% 3.4% 5.5%
Net margin -2.6% 2.7% 4.1%
FCF margin 3.6% 8.1% 7.6%
Operating cash flow margin 6.8% 10.9% 11.6%
Return on equity -285.2% 6.0% 11.9%
Return on assets -2.1% 1.3% 3.8%
Return on invested capital 0.0% 4.1% 9.0%
Return on capital employed 0.7% 4.6% 9.9%
Asset turnover 0.8x 0.5x 0.9x
Cash conversion (OCF / net income) -2.6x 3.9x 2.8x
Stock comp / revenue 0.4% 0.3% 0.3%

Financial Health

11 metrics
MetricCCCELYB
Debt / assets 52.6% 55.1% 35.5%
Debt / equity 24.6x 2.5x 1.1x
Net debt / EBITDA 8.6x 6.2x 2.2x
Debt / FCF 18.2x 14.5x 5.1x
Liabilities / assets 97.9% 77.9% 67.6%
Equity / assets 2.1% 22.1% 32.4%
Interest coverage 0.1x 1.1x 5.1x
Current ratio 1.8x 1.3x 1.8x
Quick ratio 0.9x 0.7x 1.0x
Cash ratio 0.4x 0.3x 0.5x
Altman Z-score 1.43 1.54 2.73

Shareholder Returns

7 metrics
MetricCCCELYB
Dividend yield 2.7% 0.2% 5.3%
Net buyback yield -0.2% – –
Shareholder yield 2.5% 0.2% 5.3%
Payout ratio (earnings) -35.1% 5.1% 85.6%
Payout ratio (FCF) 25.6% 1.8% 46.2%
Dividend growth (1Y) -45.5% -83.7% -36.6%
Dividend CAGR (3Y) -28.7% -64.2% -11.2%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCCCELYB
Forward P/E 15.1xFY2026 8.0xFY2026 7.0xFY2026
EPS, next fiscal year $0.88FY2026 $6.46FY2026 $9.21FY2026
EPS growth, next FY -7.4%FY2026 +62.3%FY2026 +441.8%FY2026
EPS growth, the year after +109.1% -0.3% -27.4%
Revenue, next fiscal year $5.76BFY2026 $9.71BFY2026 $31.89BFY2026
Revenue growth, next FY -0.9%FY2026 +1.7%FY2026 +5.8%FY2026
Revenue growth, the year after +2.7% +8.4% +2.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCCCELYB
Held by institutions 89.4% 100.0% 37.4%
Institutions holding 472 458 880
Change in shares held, QoQ +2.8% +10.8% -1.9%
Institutions buying 213 246 469
Institutions selling 127 138 299
Buyers to sellers 1.68 1.78 1.57

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CCCELYB
CC 1.00 0.51 0.30
CE 0.51 1.00 0.65
LYB 0.30 0.65 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CC, CE and LYB?

LyondellBasell Industries (LYB) is the largest by market capitalisation: Chemours (CC) $1.89B, Celanese (CE) $5.39B, LyondellBasell Industries (LYB) $39.96B.

Which stock is cheaper, CC, CE and LYB?

Celanese (CE) trades on the lowest price-to-earnings ratio (Chemours (CC) -12.3x, Celanese (CE) 20.6x, LyondellBasell Industries (LYB) 30.9x). On next year's consensus earnings, LyondellBasell Industries (LYB) is cheapest (Chemours (CC) 15.1x, Celanese (CE) 8.0x, LyondellBasell Industries (LYB) 7.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

LyondellBasell Industries (LYB) grew revenue fastest over the trailing twelve months: Chemours (CC) +0.1%, Celanese (CE) +1.6%, LyondellBasell Industries (LYB) +3.5%.

Which company is more profitable?

LyondellBasell Industries (LYB) has the highest net margin (Chemours (CC) -2.6%, Celanese (CE) 2.7%, LyondellBasell Industries (LYB) 4.1%). On return on invested capital, LyondellBasell Industries (LYB) leads (Chemours (CC) 0.0%, Celanese (CE) 4.1%, LyondellBasell Industries (LYB) 9.0%).

Which stock has performed better?

Over the past year LyondellBasell Industries (LYB) returned the most: Chemours (CC) +8.2%, Celanese (CE) +28.6%, LyondellBasell Industries (LYB) +41.5%. Over five years, LyondellBasell Industries (LYB) compounded fastest (Chemours (CC) -16.7%/yr, Celanese (CE) -21.3%/yr, LyondellBasell Industries (LYB) -7.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Chemours (CC) has the highest dividend yield: Chemours (CC) 0.03%, Celanese (CE) 0.00%, LyondellBasell Industries (LYB) 0.03%.

Which stock is riskier?

By one-year price volatility, LyondellBasell Industries (LYB) has been the steadiest (Chemours (CC) 61.9%, Celanese (CE) 49.6%, LyondellBasell Industries (LYB) 42.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CC, CE and LYB?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, LyondellBasell Industries (LYB) leads on 10. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.